Depression and CHD risk: How should we intervene?
- 9 July 2007
- journal article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 9 (4) , 272-277
Abstract
Depression is common in the community and is a risk factor for the development of coronary heart disease (CHD). In patients with CHD, the prevalence of major depression is nearly 20% and the prevalence of minor depressive disorder is approximately 27%. When present in patients with existing CHD, depression is independently associated with worse outcome, including higher morbidity and mortality, and worse health status. Observational studies suggest that use of antidepressant medications in patients with CHD is associated with decreased risk of cardiovascular events. However, only one randomized controlled trial, the ENRICHD (Enhancing Recovery in Coronary Heart Disease) study, was designed to evaluate whether treatment of depression in patients with CHD can improve cardiac prognosis. Although the study showed that cognitive behavior therapy was better than usual care in improving depression, there was no improvement in all-cause mortality or recurrent cardiac events. There have been no clinical trials specifically designed to evaluate whether pharmacologic treatment of depression improves cardiovascular outcomes in patients with CHD. Thus, there is a clear need for additional trials testing interventions to improve cardiac prognosis based on treatment of depression. In the meantime, depression remains an important illness in its own right and deserves treatment. Safe and effective treatments of depression in patients with CHD include cognitive behavior therapy and selective serotonin reuptake inhibitors.Keywords
This publication has 41 references indexed in Scilit:
- Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery DiseaseJAMA, 2007
- Depression and Cardiovascular DiseaseJAMA, 2006
- Screening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study)The American Journal of Cardiology, 2005
- Pharmacologic Treatment of Depression in Patients With Heart DiseasePsychosomatic Medicine, 2005
- Patients With Depressive Symptoms Have Lower Health Status Benefits After Coronary Artery Bypass SurgeryCirculation, 2005
- Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysisPsychosomatic Medicine, 2004
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- History of depression, angina, and quality of life after acute coronary syndromesAmerican Heart Journal, 2003
- The PHQ-9Journal of General Internal Medicine, 2001
- Selective Serotonin Reuptake Inhibitors for Late-Life DepressionDrugs & Aging, 2001